Advertisement

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

ACCEPT AND CLOSE

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

The key to knowledge is in your (nitrile-gloved) hands

Already an ACS Member?  

Basic

$0 Community Associate

ACS’s Basic Package keeps you connected with C&EN and ACS.

  • Access to 6 digital C&EN articles per month on cen.acs.org
  • Weekly delivery of the C&EN Essential newsletter
JOIN NOW
Standard

$80 Regular Members & Society Affiliates

ACS’s Standard Package lets you stay up to date with C&EN, stay active in ACS, and save.

Eligibility restrictions apply. Review ACS Membership Packages to see if you qualify.

JOIN NOW
Premium

$160 Regular Members & Society Affiliates
$55 Graduate Students
$25 Undergraduate Students

ACS’s Premium Package gives you full access to C&EN and everything the ACS Community has to offer.

  • Unlimited access to C&EN’s daily news coverage on cen.acs.org
  • Weekly delivery of the C&EN Magazine in print or digital format
  • Access to our Chemistry News by C&EN mobile app
  • Significant discounts on registration for most ACS-sponsored meetings
ACS offers discounts for some countries outside the United States. This discount is shown at checkout, if applicable.

JOIN NOW

Thank you!

Your account has been created successfully, and a confirmation email is on the way.

Your username is now your ACS ID.

ENJOY UNLIMITED ACCES TO C&EN
« Prev
Next »
Copyright © 2024 American Chemical Society

March 4, 2024 Cover

Volume 102, Issue 7

Cleantech start-ups vie for a piece of the PFAS destruction market

Full Article
Volume 102 | Issue 7
« Prev
Next »

All Issues

Quote of the Week

“Our mission is to end PFAS, not to beat the other guys who are ending PFAS.”

Nigel Sharp, CEO and cofounder, Aquagga

Persistent Pollutants

Competition to destroy ‘forever chemicals’ heats up

New schizophrenia medications could signal a comeback for psychiatric drugs

Muscarinic agonists may reignite Big Pharma’s interest in psychiatry

Mona Minkara talks science accessibility and the 'unseen advantage' of diversifying the lab

This Northeastern University professor discusses her experience being blind in science and the tools that might help other researchers with disabilities

  • Specialty Chemicals

    US Defense Department funds chemical capacity building

    $192.5 million will help replace critical raw materials currently sourced abroad

  • Instrumentation

    Dispatch from the lab of the future

    The Society for Laboratory Automation and Screening’s annual conference offers a glimpse into labs staffed by robots

  • Legislation

    Indiana punts on PFAS bill

    Proposed law to narrow the definition of PFAS now floats in legislative limbo

ADVERTISEMENT

Science Concentrates

More
image name
Drug Discovery

An antibiotic built for better binding

Cresomycin’s conformationally restricted structure makes a tight fit with bacterial ribosomes and pushes away methyl groups that can confer resistance

Business & Policy Concentrates

More
ADVERTISEMENT

EDITORIAL

REACTIONS FROM OUR READERS

ACS Career Tips

ACS NEWS

More

NEWSCRIPTS

image

Newscripts at the Oscars: Barbenheimer double feature

 

Job listings

visit
ADVERTISEMENT